Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001413103 | SCV001615209 | likely benign | not provided | 2024-11-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002499885 | SCV002796789 | likely benign | Age related macular degeneration 9; Atypical hemolytic-uremic syndrome with C3 anomaly; Complement component 3 deficiency | 2021-10-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003938705 | SCV004751624 | likely benign | C3-related disorder | 2019-02-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |